UGT1A1 and Hyperbilirubinemia: In summary, a stepwise diagnostic approach for CNS includes the clinical assessment of jaundice, exclusion of other causes of hyperbilirubinemia, the trial of phenobarbital in suspected CNS2 cases, and confirmation through comprehensive molecular genetic testing of the UGT1A1 gene.